Climb Bio Inc
Climb Bio Inc (CLYM) Covered Calls
As of October 23, 2026, CLYM has 24 covered call opportunities in the coming three months. Return ranges from 21.9 to 196.0% until expiration. Annualized return ranges from 23.9 to 556.5%. The nearest expiration is November 20, 2026. Maximum potential profit is $2,066.
Read more
Running CLYM covered calls helps you generate consistent income from Climb Bio Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Climb Bio Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best CLYM covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if CLYM stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling CLYM covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Climb Bio Inc covered call is worth writing.
Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. It develops budoprutug, an anti-CD19 monoclonal antibody for various autoimmune diseases, including systemic lupus erythematosus and lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wilmington, Delaware.
Income-focused investors, long-term CLYM holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling CLYM covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Climb Bio Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile—
- Market cap (M$)585
- 52 weeks high-44.41%
- 52 weeks low521.34%
- Analyst recommendationStrong Buy
1.06 - Target price$27.50
169.87% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-11
- P/E—
- Future P/E—
- EPS (ttm)-0.83
- EPS growth next 5 years-15.55%
As of October 23, 2026
| 2026-11-20 | 29 | 15.00 | 42.31 | 0.20 | 1.50 | 466.00 | 44.21 | 556.47 | -1.90 | +0.32 | 117 | 1.30 |
| 2027-01-15 | 85 | 20.00 | 89.75 | 0.20 | 3.60 | 966.00 | 91.65 | 393.56 | -1.90 | +0.42 | 17 | 3.40 |
| 2026-11-20 | 29 | 12.50 | 18.60 | 0.80 | 1.20 | 276.00 | 26.19 | 329.58 | -7.59 | +0.41 | 269 | 0.40 |
| 2027-01-15 | 85 | 17.50 | 66.03 | 0.20 | 2.40 | 716.00 | 67.93 | 291.71 | -1.90 | +0.36 | 25 | 2.20 |
| 2026-12-18 | 57 | 15.00 | 42.31 | 0.05 | 1.60 | 451.00 | 42.79 | 274.00 | -0.47 | +0.32 | 1,630 | 1.55 |
| 2027-02-19 | 120 | 17.50 | 66.03 | 0.40 | 1.75 | 736.00 | 69.83 | 212.40 | -3.80 | +0.33 | 41 | 1.35 |
| 2027-01-15 | 85 | 15.00 | 42.31 | 0.30 | 4.20 | 476.00 | 45.16 | 193.93 | -2.85 | +0.50 | 21 | 3.90 |
| 2027-05-21 | 211 | 20.00 | 89.75 | 0.30 | 4.40 | 976.00 | 92.60 | 160.18 | -2.85 | +0.47 | 3 | 4.10 |
| 2027-05-21 | 211 | 17.50 | 66.03 | 0.80 | 4.90 | 776.00 | 73.62 | 127.36 | -7.59 | +0.53 | 0 | 4.10 |
| 2027-02-19 | 120 | 12.50 | 18.60 | 1.35 | 2.35 | 331.00 | 31.40 | 95.52 | -12.81 | +0.51 | 3 | 1.00 |
As of October 23, 2026
Sell covered calls with the data behind you
Find the best CLYM covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→